Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1

BACKGROUND: Previous studies using pegylated interferon (Peg-IFN) and ribavirin (RBV) combination therapy suggested that patients with hepatitis C virus (HCV) genotype 1 and low pretreatment HCV RNA level who achieved rapid virological response (RVR) can be treated for 24 weeks without compromising...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepat Mon
Hlavní autoři: Sharafi, Heidar, Alavian, Seyed Moayed, Keshvari, Maryam
Médium: Artigo
Jazyk:Inglês
Vydáno: Kowsar 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4330713/
https://ncbi.nlm.nih.gov/pubmed/25741374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.24955
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky